Q1 2026 Xtant Medical Holdings Inc Earnings Call Transcript
Key Points
- Xtant Medical Holdings Inc (XTNT) achieved significant milestones, including a transformational license agreement with Dillon Technologies, entering the multibillion-dollar hemostatic agent market.
- The company raised its full-year 2026 revenue guidance to $101 million to $105 million, reflecting confidence in future growth.
- The commercial launch of Trivium Shaped, an extension of the TRIVIUM bone graft portfolio, enhances product offerings and supports surgical applications.
- Xtant Medical Holdings Inc (XTNT) strengthened its balance sheet by reducing total indebtedness by $13.3 million in the first quarter of 2026.
- The acquisition of exclusive US distribution rights to Dillon's Hemoblast Bellose product provides entry into a $2 billion global addressable market for hemostatic products.
- Total revenue for the first quarter of 2026 was $20.9 million, a decrease from $32.9 million in the first quarter of 2025.
- Gross margin for the first quarter of 2026 decreased to 57.3% from 61.5% in the same period in 2025, due to changes in the reimbursement environment.
- Net loss for the first quarter of 2026 was $3.1 million, compared to net income of $58,000 for the first quarter of 2025.
- Adjusted EBITDA for the first quarter of 2026 was a loss of $1.6 million, compared to a positive adjusted EBITDA of approximately $3 million in 2025.
- The company experienced a decline in revenue from its amnio product line, directly tied to the advanced wound care market.
Good morning, everyone, and thank you, and welcome to the Xstant Medical First Quarter 2026 Financial Results.
At this time, all participants are in a listen-only mode. The floor will be open for questions and comments following the presentation. Please note this conference is being recorded. I will now turn the conference over to your host, Kevin Gardner of LifeSci Advisors.
Thank you, operator, and welcome to Extant Medical's first quarter 2026 financial results call.
Joining me today are Seann Brown, President and Chief Executive Officer, and Scott Neals, Chief Financial Officer.
Today's call is being webcast and will be posted on the company's website for playback.
During the course of this call, management may make certain forward-looking statements regarding future events and the company's expected future performance.
These forward-looking statements reflect Extant's current perspective on existing trends and information and can be identified by such words as expect, plan, will, may, anticipate, believe, should, intends, and other words with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
